SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Given Imaging (GIVN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: caly11/29/2004 10:29:21 AM
   of 29
 
Given Imaging Announces Marketing Clearance for 14 Frame PillCam ESO Video Capsule for the Esophagus

Monday November 29, 4:08 am ET

YOQNEAM, Israel--(BUSINESS WIRE)--Nov. 29, 2004--Given Imaging (Nasdaq: GIVN - News), the global leader in capsule endoscopy, today announced that it received marketing clearance from the U.S. Food and Drug Administration (FDA) for the 14 frame PillCam(TM) ESO video capsule for visualization of the esophageal mucosa together with the new RAPID 3 software that includes numerous features and enhancements.

Given Imaging will immediately begin marketing and selling the new RAPID3 software, upgrading eligible customers , and delivering PillCam ESO to market.

With this FDA clearance, Given Imaging will receive the first milestone payment from Ethicon Endo-Surgery amounting to $10 million . This amount will be recorded on a straight line over the 15 year life of the agreement as a reduction in marketing expenses.

About Given Imaging

Given Imaging is redefining gastrointestinal diagnosis by developing, producing and marketing innovative, patient-friendly products for detecting gastrointestinal disorders. The company is developing a complete line of PillCam video capsules for detecting disorders throughout the gastrointestinal tract. The company's technology platform is the Given® Diagnostic System, featuring the PillCam(TM) video capsule, a disposable, miniature video camera contained in a capsule, which is ingested by the patient. The PillCam(TM) SB video capsule is the only naturally ingested method for direct visualization of the entire small intestine. It is currently marketed in the United States and in more than 60 other countries and has benefited more than 145,000 patients worldwide. The PillCam(TM) ESO video capsule, which provides visual examination of the esophagus, has been cleared for marketing by the FDA. Additional capsules for visualization of the stomach and colon are under development. Given Imaging's headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel; it has direct sales and marketing operations in the United States, Germany and France, and local offices in Tokyo, Madrid and Sydney. For more information, visit givenimaging.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext